A novel and robust homogeneous fluorescence-based assay using nanoparticles for pharmaceutical screening and...

Area of Science:

• Biotechnology
• Analytical Chemistry
• Immunochemistry

Background:

• Homogeneous immunoassays are crucial for diagnostics and drug screening.
• Existing methods can be time-consuming and require washing steps.
• Nanoparticle-based assays offer potential for improved sensitivity and speed.

Purpose of the Study:

• To establish a novel nanoparticle immunoassay (NPIA) utilizing fluorescence intensity distribution analysis (FIDA).
• To demonstrate the capability of NPIA for characterizing single fluorescently labeled molecules and determining concentrations.
• To present adaptable NPIA formats for diverse immunoassay applications.

Main Methods:

• Development of NPIA using antibody-conjugated nanoparticles (artificial beads or bacteria).
• Application of fluorescence intensity distribution analysis (FIDA) for particle characterization.
• Implementation of two assay formats: direct conjugate labeling and sandwich ELISA-like setup.

Main Results:

• NPIA accurately quantifies molecular brightness and concentration by analyzing nanoparticle complex fluorescence.
• Demonstrated robustness, high signal-to-noise ratio, and short measurement times.
• Successful miniaturization to a 1 microl/well format with no washing steps required.

Conclusions:

• NPIA provides a sensitive, rapid, and straightforward immunoassay platform.
• The method is suitable for high-throughput pharmaceutical screening and diagnostics.
• NPIA significantly reduces assay development time through a versatile toolbox approach.